Company profile
RushNet, Inc.
OTC: RSHN · Healthcare · Medical - Diagnostics & Research
#1 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 51
v0.1 · 5/100 weight · pillars only
↑ listing tenure, Altman-Z · ↓ filing timeliness, Piotroski F
Methodology →Revenue TTM
$3.9M
Rev growth YoY (TTM)
-43.0%
Net income (FY)
—
Employees
17
as of 2026-08-26
Market cap
$857.6k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
No filed financials — private or non-XBRL filer.
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is RushNet, Inc.’s financial profile?
RushNet, Inc. has no structured financials on file — private or non-XBRL filer.
Peers · Healthcare
PharmaCom BioVet, Inc.——Suvanza Pharma, LLC——Lakewood-Amedex Biotherapeutics Inc. Common Stock——ZyVersa Therapeutics, Inc.——XORTX Therapeutics Inc.——China Health Management Corp.——Neighbors
Cook →Key facts
CEOMichael A. Cunha
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersBlue Island, IL
ExchangeOTC: RSHN
Employees17
IPO date1998-10-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.